Cargando…
Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer
BACKGROUND: Epithelial ovarian cancer (EOC) has been classified into four molecular subtypes, of which the mesenchymal subtype has the poorest survival. Our goal is to develop an immune-based prognostic signature by incorporating molecular subtypes for EOC patients. METHODS: The gene expression prof...
Autores principales: | Sheng, Mingyan, Tong, Haofei, Lu, Xiaoyan, Shanshan, Ni, Zhang, Xingguo, Reddy, B. Ashok, Shu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545305/ https://www.ncbi.nlm.nih.gov/pubmed/33031300 http://dx.doi.org/10.1097/MD.0000000000022549 |
Ejemplares similares
-
Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer
por: Zhang, Bin, et al.
Publicado: (2020) -
Prognostic implications of an autophagy-based signature in colorectal cancer
por: Wang, Liangbin, et al.
Publicado: (2021) -
Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer
por: Li, Jingtai, et al.
Publicado: (2023) -
Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023) -
The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
por: Liu, Lin, et al.
Publicado: (2023)